AbstractThe role of microRNA-30a (miR-30a) deregulation in tumor progression and its downstream signaling pathways remain unknown. Here we confirmed significant downregulation of miR-30a in hepatocellular carcinoma (HCC) tissues and cell lines compared with non-tumor counterparts. MiR-30a downregulation was significantly associated with worse disease-free survival (DFS) of HCC patients. Gain- and loss-of-function studies revealed that downregulation of miR-30a facilitated tumor cell migration, invasion and epithelial–mesenchymal transition (EMT). We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1, indicating its potential therapeutic value for reducing invasion and metas...
AbstractHepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide....
Objective: To investigate the potential biomarkers for venous metastasis of hepatocellular carcinoma...
Objective(s): Growing evidences have indicated microRNAs as modulators of tumor development and aggr...
AbstractThe role of microRNA-30a (miR-30a) deregulation in tumor progression and its downstream sign...
Background/Aims: The activation of hepatic stellate cells (HSCs) is considered as a pivotal event in...
The molecular background of hepatocellular carcinoma (HCC) is highly heterogeneous, and biomarkers p...
Human esophagus carcinoma (EC) is one of the most common malignant tumors, especially in Africa and ...
[[abstract]]Hepatocellular carcinoma (HCC) remains one of the most lethal human cancer globally. For...
Producción CientíficaHepatocellular carcinoma (HCC) is the second leading cause of cancer-related de...
microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 Hu...
AbstractMicroRNAs (miRNAs) have been linked to the molecular pathogenesis of many cancers. In this s...
BACKGROUND: For treatment and prevention of metastatic disease, one of the premier challenges is the...
Creative Commons Attribution 3.0 LicenseEarly-staged cholangiocarcinoma (CCA) is difficult to diagno...
Background/Aims: Previous studies have confirmed that microRNAs are involved in the metastasis and e...
Abstract Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths, worldwide. Mi...
AbstractHepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide....
Objective: To investigate the potential biomarkers for venous metastasis of hepatocellular carcinoma...
Objective(s): Growing evidences have indicated microRNAs as modulators of tumor development and aggr...
AbstractThe role of microRNA-30a (miR-30a) deregulation in tumor progression and its downstream sign...
Background/Aims: The activation of hepatic stellate cells (HSCs) is considered as a pivotal event in...
The molecular background of hepatocellular carcinoma (HCC) is highly heterogeneous, and biomarkers p...
Human esophagus carcinoma (EC) is one of the most common malignant tumors, especially in Africa and ...
[[abstract]]Hepatocellular carcinoma (HCC) remains one of the most lethal human cancer globally. For...
Producción CientíficaHepatocellular carcinoma (HCC) is the second leading cause of cancer-related de...
microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1 Hu...
AbstractMicroRNAs (miRNAs) have been linked to the molecular pathogenesis of many cancers. In this s...
BACKGROUND: For treatment and prevention of metastatic disease, one of the premier challenges is the...
Creative Commons Attribution 3.0 LicenseEarly-staged cholangiocarcinoma (CCA) is difficult to diagno...
Background/Aims: Previous studies have confirmed that microRNAs are involved in the metastasis and e...
Abstract Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths, worldwide. Mi...
AbstractHepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide....
Objective: To investigate the potential biomarkers for venous metastasis of hepatocellular carcinoma...
Objective(s): Growing evidences have indicated microRNAs as modulators of tumor development and aggr...